Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.

Molecular Cancer Therapeutics
Suresh R VolateWilliam L Farrar

Abstract

Prostate cancer continues to represent a burgeoning medical problem in the United States. Recent studies suggest that gossypol, a bioactive phytochemical produced by cotton plants, is a promising agent against prostate cancer. The current studies were undertaken to examine the chemotherapeutic efficacy of gossypol on human prostate cancer cell lines and prostate tumor-initiating cells. Gossypol reduced the viability of three prostate cancer cell lines (LAPC4, PC3, and DU145) with an IC(50) between 3 and 5 micromol/L. Additionally, gossypol was effective at inhibiting prostate tumor-initiating cell-driven tumor growth in a nonobese diabetic/severe combined immunodeficient xenograft model. Our integrated molecular profiling approach encompassing proteomics, activated transcription factors, and genomics suggests that the decrease in viability was associated with increased DNA damage and the induction of apoptosis. Exposure of DU145 cells to gossypol (1-10 micromol/L) resulted in the activation of 13 proteins and 7 transcription factors, and the expression of 17 genes involved in the mitochondrial pathway of apoptosis. These studies show for the first time that gossypol treatment induces DNA damage and activates p53. Collectively, ...Continue Reading

References

Jan 1, 1992·Cancer Chemotherapy and Pharmacology·R C SteinR C Coombes
Oct 1, 1986·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·F HuD J Teramura
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·S Z Qian, Z G Wang
Apr 18, 2000·Mutation Research·M S ColmanJ C Barrett
Oct 26, 2000·Nature·M O Hengartner
Nov 1, 2005·Expert Opinion on Investigational Drugs·Kalliopi DodouPaul W Groundwater
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity·Matthew R Smith
Sep 25, 2008·Ernst Schering Foundation Symposium Proceedings·P Rustin, G Kroemer
Oct 9, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Jill A MacoskaCheryl T Lee
Jan 21, 2009·Der Urologe. Ausg. A·F G E PeraboP J Bastian
Mar 6, 2009·Cancer Letters·Shyamal K Goswami, Dipak K Das

❮ Previous
Next ❯

Citations

Nov 20, 2012·Cell Biochemistry and Biophysics·Muge SenarisoyZeki Topcu
Jun 8, 2011·Antioxidants & Redox Signaling·Simone Fulda, Guido Kroemer
May 30, 2014·Drug Design, Development and Therapy·Chengyuan QianDong Wang
Sep 10, 2014·BioMed Research International·Renhua XuQingtao Wang
Sep 3, 2014·BioMed Research International·Lixu JinRenshan Ge
Oct 23, 2012·Clinical Genitourinary Cancer·Connor HallMin H Kang
Mar 17, 2016·Drug Discovery Today·Milla KibbleTero Aittokallio
Mar 6, 2015·Expert Opinion on Therapeutic Patents·Chien-Hsing Lee, Chung-Yi Chen
Dec 25, 2012·Biochemical Pharmacology·Joana Dias AmaralCecília Maria Pereira Rodrigues
Feb 11, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Vered Heleg-ShabtaiItamar Willner
Mar 28, 2013·Molecular BioSystems·Jia WangHaiteng Deng
Jul 20, 2017·Future Medicinal Chemistry·Yuzhi LuWei Wang
May 1, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yong-Sheng ZhangHai-Rong Li
Mar 10, 2017·Breast Cancer Research : BCR·Jing XiongSheng Zhou
Jun 29, 2017·Molecular Medicine Reports·Ming-Dong LuZhi-Qiang Zheng
Sep 27, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Robert Matthew KottmannPatricia J Sime
Sep 5, 2017·Frontiers in Pharmacology·Philipp Wolf
Mar 3, 2018·Clinical and Experimental Pharmacology & Physiology·Cing-Yu ChenShu-Er Yang
Aug 29, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chellappagounder ThangavelRobert B Den
Aug 14, 2021·Critical Reviews in Food Science and Nutrition·Tahreem RiazMuhammad Bilal
May 6, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jian XuYing-Wei Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis